Detalhe da pesquisa
1.
The impact of nerve sparing on incidence and location of positive surgical margins in radical prostatectomy.
BJU Int
; 109(4): 533-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21711436
2.
High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
BJU Int
; 109(12): 1794-800, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21992536
3.
High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse.
BJU Int
; 110 Suppl 4: 71-6, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23194129
4.
Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.
Prostate
; 71(15): 1638-45, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21432866
5.
Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram.
BJU Int
; 105(5): 642-7, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19751263
6.
HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer.
Mol Cell Endocrinol
; 301(1-2): 89-96, 2009 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19100308
7.
The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome.
Cancer Res
; 65(6): 2330-6, 2005 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15781647
8.
Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.
Cancer Epidemiol Biomarkers Prev
; 15(4): 711-6, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16614113
9.
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.
Cancer Res
; 63(14): 4196-203, 2003 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12874026
10.
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.
Oncogene
; 22(38): 6005-12, 2003 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-12955079